SPOTLIGHT: Big Pharma spurns Biogen Idec


Big Pharma just wasn't big enough to swallow Biogen Idec. A slew of drug makers kicked tires at the biotech company, but eventually concluded that the price was too high; after getting no definitive offers, Biogen took itself off the market. Release

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.